I. Horvath (Budapest, Hungary), G. Di Maria (Catania, Italy)
Similar exhaled nitric oxide concentration in atopic and nonatopic adults without respiratory symptoms; reference values for clinical use
A. Rouhos, A. Kainu, S. Sarna, J. Karjalainen, A. R. Sovijärvi (Helsinki, Finland)
|  |
Increased exhaled NO after reversal of the late asthmatic response by β2-agonists
D. J. Boot, S. Tarasevych, P. J. Sterk, L. Wang, D. Amin, A. F. Cohen, Z. Diamant (Leiden, Netherlands; Bridgewater, United States Of America)
| |
Hyperinflation is associated with reduced nitric oxide production in COPD
K. Roy, Z. Borrill, C. Starkey, J. Vestbo, D. Singh (Manchester, United Kingdom)
| |
Measurement of bronchial and peripheral airway nitric oxide production by multiple exhalation flow rates in children with PCD
E. Paraskakis, N. Zihlif, N. M. Wilson, A. Bush (London, United Kingdom)
| |
Correlation between nitrogen oxide in the gas phase and inflammation markers in the EBC
M. Decker, G. Becher, M. Rothe, K. Stephan, L. Fred, B. Ekkehard (Berlin, Potsdam, Ruedersdorf, Germany)
| |
Conductivity in exhaled breath condensate of patients with asthma, COPD or cystic fibrosis
A. S. Theis, A. Bergner, R. Fischer, A. Kronseder, R. A. Jörres, R. M. Huber (Munich, Germany)
| |
Elevated TNF-α and interleukin-6 levels in breath condensate and serum of patients with non-CF bronchiectasis: comparison to COPD
E. Bucchioni, K. Dimakou, F. Blasi, P. Bakakos, S. Galbiati, B. Dallari, L. Allegra (Milan, Italy; Athens, Greece)
| |
Effects of childhood asthma and inhaled corticosteroid treatment on EBC levels of IL-4 and TNF-α
T. F. Leung, G. W. K. Wong, F. W. S. Ko, C. Y. Li, E. Yung, T. F. Fok (Hong Kong, Hong Kong)
| |
Monitoring the effect of fixed combination therapy by exhaled biomarkers in asthmatic children
E. Barát, E. Huszár, M. Valyon, E. Péterfy, G. Baktai, I. Horváth (Budapest, Hungary)
| |
Normative values for exhaled breath condensate pH
A. Paget-Brown, A. Smith, D. Bunyan, S. Hom, T. Nguyen, P. Urban, B. Walsh, J. F. Hunt (Charlottesville, United States Of America)
| |
Airway hyperresponsiveness in asymptomatic subjects: is bronchial provocation with mannitol a more specific test?
C. M. Porsbjerg, R. M. Linda, T. F. Simon, B. John, A. Sandra, B. Vibeke (Copenhagen, Denmark; Camperdown, Australia)
| |
Use of the exhaled breath condensate in the study of airway inflammation after hypertonic saline challenge
G. E. Carpagnano, O. Resta, M. G. Cagnazzo, G. Di Gioia, T. Giliberti, P. Bonfitto, P. Carratu‘, M. P. Foschino-Barbaro (Foggia, Bari, Italy)
| |
Eucapnic voluntary hyperpnea: correlation between response and airway inflammation
M. Agrafiotis, D. Simoes, N. Rovina, E. Dima, O. Georgiadou, C. Gratziou (Athens, Greece)
| |
Salbutamol attenuates nasal symptoms and mast cell degranulation by AMP challenge
C. Russo, D. Zeng, L. Spicuzza, L. Daniela, R. Polosa (Catania, Italy; Palo Alto, United States Of America)
| |
Lack of evidence for mast cell activation following positive inhaled adenosine challenge
G. Bochenek, E. Nizankowska, K. Nagraba, A. Gielicz, A. Szczeklik (Cracow, Poland)
| |
Biomarkers of human asthma; the effect of inhaled AMP on exhaled nitric oxide and circulating VEGF levels
G. W. Clarke, D. E. Simcock, C. L. Ledbetter, A. Greenough, B. J. O‘Connor (London, United Kingdom)
| |
Regional ventilatory defects on induced bronchoconstriction in normal subjects
N. A. Marks, W. E. Svensson, A. M. Al-Nahhas, P. W. Ind (London, United Kingdom)
| |
Regional ventilatory in asthma
N. A. Marks, W. E. Svensson, A. M. Al-Nahhas, P. W. Ind (London, United Kingdom)
| |
Ventilatory inhomogeneity of the acinar region of the lung is demonstrated in acute severe asthma
M. A. Rees, J. A. Douglass, M. Ellis, G. G. King, B. R. Thompson (Melbourne, Sydney, Australia)
| |
Measurement of airway hyperresponsiveness in preschool children by determining dead space/tidal volume quotient (VD/VT)
I. Laki, J. Laki, G. Szekely, K. Gyurkovits (Mosdos, Hungary)
| |